Khaled El Emam

Five barriers to the commercialization of medical AI research

• Consistent and significant investments in AI research in Canada have resulted in globally recognized centres of academic excellence across the country. The often-repeated challenge

Opinion | BY KHALED EL EMAM | March 30, 2022

Five barriers to the commercialization of medical AI research

Opinion | BY KHALED EL EMAM | March 30, 2022

• Consistent and significant investments in AI research in Canada have resulted in globally recognized centres of academic excellence across the country. The often-repeated challenge

Five barriers to the commercialization of medical AI research

Opinion | BY KHALED EL EMAM | March 30, 2022

• Consistent and significant investments in AI research in Canada have resulted in globally recognized centres of academic excellence across the country. The often-repeated challenge

Five barriers to the commercialization of medical AI research

• Consistent and significant investments in AI research in Canada have resulted in globally recognized centres of academic excellence across the country. The often-repeated challenge

Opinion | BY KHALED EL EMAM | March 30, 2022

Five barriers to the commercialization of medical AI research

Opinion | BY KHALED EL EMAM | March 30, 2022

• Consistent and significant investments in AI research in Canada have resulted in globally recognized centres of academic excellence across the country. The often-repeated challenge

Five barriers to the commercialization of medical AI research

Opinion | BY KHALED EL EMAM | March 30, 2022

• Consistent and significant investments in AI research in Canada have resulted in globally recognized centres of academic excellence across the country. The often-repeated challenge

More Stories